Virginia Regulatory Town Hall
Agency
Department of Health Professions
Board
Board of Pharmacy
Meeting:
Public hearing - scheduling of chemicals in Schedule I per DFS recommendations. Hearing is not related to petition for rulemaking regarding kratom.

 
Meeting Details
Date / Time 6/25/2024  9:05 am
Type Physical Location Only 
Location Board Room 2
9960 Mayland Drive, Suite 201
Henrico, Virginia 23233  
Board Website http://www.dhp.virginia.gov 
Agenda document agency has not posted
Minutes document pdf Meeting minutes 7/5/2024   (114k)       DRAFT
Disability Friendly? Yes       Deaf interpreter available upon request? Yes
Purpose of the meeting
The Board will receive comment on recommendations from DFS for scheduling of chemicals in Schedule I. This hearing does not involve a recent petition for rulemaking to the Board regarding the scheduling of kratom. This hearing only involves the following chemicals, recommended for placement in Schedule I by DFS: Pursuant to article § 54.1-3443(D), The Virginia Department of Forensic Science (DFS) has identified four (4) compounds for recommended inclusion into the Code of Virginia. Based on their chemical structures, the following compounds are expected to have hallucinogenic properties. Compounds of this type have been placed in Schedule I (§ 54.1-3446(3)) in previous legislative sessions. 1-[(4-fluorophenyl)methyl]-4-methylpiperazine (other names: 4-fluoro-MBZP, 4-fluoro methylbenzylpiperazine), its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. 4-fluoro-alpha-pyrrolidinoisohexiophenone (other name: 4-fluoro-alpha-PiHP), its salts, isomers (optical, position, and geometric), and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. 8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (other name: pyrazolam), its salts, isomers (optical, position, and geometric), and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. The following compound is classified as a cannabimimetic agent. Compounds of this type have been placed in Schedule I (§ 54.1-3446(6)) in previous legislative sessions. Methyl-2-(1-butyl-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: MDMB-BUTINACA), its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
Meeting Scope
 
Public hearing to receive comment on a proposed stage
 
General business of the board
X
Discuss particular regulations / chapters
The agency plans to discuss the following regulations at this meeting:
18 VAC 110-20 Regulations Governing the Practice of Pharmacy

Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Henrico, 23233
Email Address: caroline.juran@dhp.virginia.gov
Telephone: (804)367-4456    FAX: (804)527-4472    TDD: ()-